Share Price and Basic Stock Data
Last Updated: December 9, 2025, 8:22 pm
| PEG Ratio | -1.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deccan Cements Ltd operates within the competitive cement industry, a sector known for its cyclical nature and significant reliance on infrastructure development. The company reported sales of ₹782 Cr for the fiscal year ending March 2023, reflecting a marginal decline from ₹792 Cr the previous year. This fluctuation is indicative of the challenges the company faces in maintaining revenue stability. In the trailing twelve months (TTM), sales stood at ₹505 Cr, further highlighting the revenue pressures in recent quarters. The revenue trend shows a mixed performance; while the December 2023 quarter witnessed a bounce back with sales of ₹217 Cr, the subsequent quarters seem to indicate a decline in momentum, with a drop to ₹120 Cr by September 2024. Such variability raises questions about the company’s ability to sustain growth amid fluctuating demand and rising competition.
Profitability and Efficiency Metrics
Profitability metrics for Deccan Cements reveal a concerning trend. The operating profit for FY 2025 fell to ₹35 Cr, significantly lower than the ₹96 Cr recorded in the previous fiscal year. This decline is accompanied by a shrinking operating profit margin (OPM), which stood at just 7% in FY 2025 compared to 12% in FY 2024. The net profit also took a hit, dropping to ₹8 Cr in FY 2025 from ₹37 Cr in FY 2024. Such figures suggest that the company is struggling with cost management, as expenses have risen to ₹492 Cr in FY 2025, up from ₹704 Cr the prior year. The interest coverage ratio is a relatively healthy 4.04x, indicating that while the company can cover its interest obligations, its overall profitability appears stretched. Investors may find these profitability metrics a cause for concern as they reflect the company’s challenges in enhancing operational efficiency and managing costs effectively.
Balance Sheet Strength and Financial Ratios
Deccan Cements’ balance sheet presents a mixed picture of strength and vulnerability. The company reported total borrowings of ₹760 Cr, which is notably higher than its reserves of ₹739 Cr, suggesting a reliance on debt financing that could pose risks, especially in a rising interest rate environment. The debt-to-equity ratio stands at 0.98x, indicating that the company is nearly at a 1:1 leverage ratio, which could be perceived as risky by investors. On a more positive note, the current ratio is a comfortable 1.17x, suggesting that Deccan Cements has sufficient short-term assets to cover its short-term liabilities. Furthermore, the price-to-book value ratio of 1.52x indicates that the stock is trading at a premium to its book value, which could be a sign of investor confidence, but also raises concerns about valuation in light of declining profitability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Deccan Cements reflects a stable yet cautious investor sentiment. Promoters hold a significant 56.24% stake, which provides a sense of stability. However, foreign institutional investors (FIIs) have shown a slight decline in their holdings, dropping from a peak of 11.87% in September 2024 to 9.93% in September 2025. This reduction may indicate waning confidence among international investors regarding the company’s growth prospects. Domestic institutional investors (DIIs) remain minimal at around 0.90%, suggesting that institutional interest is limited. The public holding is at 32.92%, with the number of shareholders declining from 17,605 in December 2022 to 11,952 by September 2025. This trend could indicate a lack of retail investor enthusiasm, which is essential for driving stock liquidity and market participation.
Outlook, Risks, and Final Insight
Looking ahead, Deccan Cements faces a slew of challenges and opportunities. The company’s reliance on debt financing is a significant risk, particularly if interest rates continue to rise, potentially squeezing margins further. Additionally, the volatility in revenue and profitability metrics suggests that the company may struggle to maintain investor confidence if operational efficiencies are not improved. However, the stable promoter holding and a relatively strong current ratio provide a buffer against immediate financial distress. Investors should consider the potential for recovery in the cement sector, driven by infrastructure projects and government spending, which could lead to better demand in the coming years. Ultimately, the path forward will depend on Deccan Cements’ ability to navigate these challenges while capitalizing on growth opportunities in a recovering market environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Deccan Cements Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 23.0/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,36,580 Cr. | 11,414 | 13,102/10,048 | 45.9 | 2,444 | 0.68 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 23,581 Cr. | 1,000 | 1,209/788 | 122 | 322 | 0.20 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 12,670 Cr. | 408 | 430/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,909 Cr. | 220 | 309/194 | 29.4 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 36,646.85 Cr | 1,869.89 | 36.36 | 573.47 | 0.55% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 180 | 211 | 196 | 192 | 167 | 217 | 223 | 172 | 120 | 115 | 119 | 151 |
| Expenses | 159 | 164 | 186 | 175 | 167 | 154 | 188 | 197 | 161 | 118 | 107 | 106 | 123 |
| Operating Profit | 35 | 17 | 25 | 21 | 25 | 14 | 29 | 26 | 11 | 2 | 9 | 13 | 28 |
| OPM % | 18% | 9% | 12% | 10% | 13% | 8% | 13% | 12% | 7% | 2% | 8% | 11% | 19% |
| Other Income | 3 | 2 | 2 | 3 | 3 | 4 | 4 | -11 | 3 | 3 | 3 | 7 | 3 |
| Interest | 3 | 3 | 3 | 4 | 2 | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 3 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | 28 | 9 | 17 | 13 | 19 | 8 | 22 | 5 | 4 | -5 | 1 | 10 | 20 |
| Tax % | 25% | 27% | 26% | 26% | 26% | 38% | 30% | 36% | 35% | -26% | 45% | 24% | 25% |
| Net Profit | 21 | 7 | 12 | 10 | 14 | 5 | 15 | 3 | 3 | -4 | 1 | 8 | 15 |
| EPS in Rs | 14.76 | 4.69 | 8.68 | 7.07 | 10.09 | 3.38 | 10.99 | 2.15 | 2.01 | -2.88 | 0.58 | 5.68 | 10.96 |
Last Updated: August 20, 2025, 11:45 am
Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 151.00 Cr., marking an increase of 32.00 Cr..
- For Expenses, as of Jun 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 106.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 15.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 19.00%, marking an increase of 8.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 10.96. The value appears strong and on an upward trend. It has increased from 5.68 (Mar 2025) to 10.96, marking an increase of 5.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 407 | 625 | 496 | 570 | 651 | 555 | 758 | 792 | 782 | 799 | 527 | 505 |
| Expenses | 383 | 343 | 511 | 396 | 484 | 556 | 477 | 582 | 630 | 684 | 704 | 492 | 453 |
| Operating Profit | 57 | 64 | 115 | 100 | 86 | 95 | 79 | 176 | 162 | 97 | 96 | 35 | 52 |
| OPM % | 13% | 16% | 18% | 20% | 15% | 15% | 14% | 23% | 20% | 12% | 12% | 7% | 10% |
| Other Income | 2 | 3 | 1 | 2 | 3 | 10 | -0 | 10 | -8 | 9 | -2 | 16 | 16 |
| Interest | 27 | 27 | 15 | 7 | 6 | 8 | 7 | 8 | 10 | 13 | 13 | 13 | 13 |
| Depreciation | 24 | 19 | 20 | 22 | 23 | 22 | 21 | 23 | 26 | 27 | 28 | 28 | 28 |
| Profit before tax | 7 | 21 | 81 | 74 | 61 | 75 | 51 | 155 | 117 | 67 | 53 | 11 | 27 |
| Tax % | 33% | 6% | 43% | 36% | 37% | 39% | -12% | 26% | 25% | 26% | 30% | 30% | |
| Net Profit | 5 | 20 | 46 | 47 | 39 | 46 | 57 | 115 | 88 | 49 | 37 | 8 | 20 |
| EPS in Rs | 3.59 | 14.20 | 32.54 | 33.48 | 27.52 | 32.88 | 40.44 | 82.19 | 62.52 | 35.20 | 26.60 | 5.38 | 14.34 |
| Dividend Payout % | 17% | 9% | 8% | 9% | 11% | 11% | 10% | 6% | 8% | 11% | 11% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 300.00% | 130.00% | 2.17% | -17.02% | 17.95% | 23.91% | 101.75% | -23.48% | -44.32% | -24.49% | -78.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -170.00% | -127.83% | -19.20% | 34.97% | 5.96% | 77.84% | -125.23% | -20.84% | 19.83% | -53.89% |
Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -35% |
| 3 Years: | -58% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 28% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 223 | 238 | 279 | 325 | 358 | 399 | 443 | 558 | 639 | 680 | 712 | 715 | 739 |
| Borrowings | 239 | 191 | 79 | 70 | 33 | 54 | 106 | 104 | 166 | 265 | 520 | 714 | 760 |
| Other Liabilities | 119 | 114 | 127 | 132 | 161 | 161 | 155 | 193 | 173 | 202 | 207 | 189 | 194 |
| Total Liabilities | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
| Fixed Assets | 373 | 356 | 342 | 377 | 363 | 354 | 378 | 446 | 453 | 440 | 423 | 402 | 389 |
| CWIP | 35 | 33 | 34 | 0 | 4 | 9 | 62 | 12 | 21 | 241 | 514 | 805 | 895 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 180 | 161 | 116 | 157 | 192 | 258 | 271 | 404 | 511 | 474 | 509 | 417 | 416 |
| Total Assets | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 760.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 714.00 Cr. (Mar 2025) to 760.00 Cr., marking an increase of 46.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,700.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 389.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 90.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 416.00 Cr.. The value appears to be declining and may need further review. It has decreased from 417.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
However, the Borrowings (760.00 Cr.) are higher than the Reserves (739.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -182.00 | -127.00 | 36.00 | 30.00 | 53.00 | 41.00 | -27.00 | 72.00 | -4.00 | -168.00 | -424.00 | -679.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 5 | 8 | 9 | 9 | 31 | 12 | 11 | 13 | 25 | 40 |
| Inventory Days | 935 | 712 | 397 | 464 | 364 | 374 | 493 | 341 | 349 | 601 | 408 | 541 |
| Days Payable | 164 | 152 | 150 | 25 | 16 | 27 | 169 | 218 | 132 | 291 | 164 | 194 |
| Cash Conversion Cycle | 793 | 587 | 251 | 446 | 357 | 356 | 355 | 135 | 227 | 323 | 268 | 386 |
| Working Capital Days | 27 | 15 | -2 | 3 | 22 | 10 | 1 | -34 | -51 | -32 | -45 | -65 |
| ROCE % | 7% | 11% | 24% | 21% | 17% | 19% | 13% | 27% | 20% | 9% | 8% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 5.00 |
| Basic EPS (Rs.) | 5.37 |
| Diluted EPS (Rs.) | 5.37 |
| Cash EPS (Rs.) | 25.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 515.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 515.74 |
| Revenue From Operations / Share (Rs.) | 376.21 |
| PBDIT / Share (Rs.) | 36.81 |
| PBIT / Share (Rs.) | 16.77 |
| PBT / Share (Rs.) | 7.67 |
| Net Profit / Share (Rs.) | 5.37 |
| NP After MI And SOA / Share (Rs.) | 5.37 |
| PBDIT Margin (%) | 9.78 |
| PBIT Margin (%) | 4.45 |
| PBT Margin (%) | 2.03 |
| Net Profit Margin (%) | 1.42 |
| NP After MI And SOA Margin (%) | 1.42 |
| Return on Networth / Equity (%) | 1.04 |
| Return on Capital Employeed (%) | 1.76 |
| Return On Assets (%) | 0.46 |
| Long Term Debt / Equity (X) | 0.75 |
| Total Debt / Equity (X) | 0.98 |
| Current Ratio (X) | 1.17 |
| Quick Ratio (X) | 0.82 |
| Dividend Payout Ratio (NP) (%) | 55.89 |
| Dividend Payout Ratio (CP) (%) | 11.80 |
| Earning Retention Ratio (%) | 44.11 |
| Cash Earning Retention Ratio (%) | 88.20 |
| Interest Coverage Ratio (X) | 4.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 |
| Enterprise Value (Cr.) | 1670.92 |
| EV / Net Operating Revenue (X) | 3.17 |
| EV / EBITDA (X) | 32.40 |
| MarketCap / Net Operating Revenue (X) | 2.09 |
| Retention Ratios (%) | 44.10 |
| Price / BV (X) | 1.52 |
| Price / Net Operating Revenue (X) | 2.09 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
- Net Profit Margin: 1.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.76% (Industry Average ROCE: 8.5%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.04% (Industry Average ROE: 80.09%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.82
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.3 (Industry average Stock P/E: 23.03)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Deccan Chambers, Hyderabad Telangana 500082 | secretarial@deccancements.com http://www.deccancements.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. P Parvathi | Chairperson & Managing Director |
| Mr. S Venkateswarlu | Whole Time Director |
| Mrs. Mahpara Ali | Director |
| Mr. Paturi Srinivasa Rao | Director |
| Mr. Srivari Chandrasekhar | Director |
| Mr. Rabindra Srikantan | Director |
FAQ
What is the intrinsic value of Deccan Cements Ltd?
Deccan Cements Ltd's intrinsic value (as of 09 December 2025) is 103.38 which is 86.43% lower the current market price of 762.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,072 Cr. market cap, FY2025-2026 high/low of 1,184/575, reserves of ₹739 Cr, and liabilities of 1,700 Cr.
What is the Market Cap of Deccan Cements Ltd?
The Market Cap of Deccan Cements Ltd is 1,072 Cr..
What is the current Stock Price of Deccan Cements Ltd as on 09 December 2025?
The current stock price of Deccan Cements Ltd as on 09 December 2025 is 762.
What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is 1,184/575.
What is the Stock P/E of Deccan Cements Ltd?
The Stock P/E of Deccan Cements Ltd is 32.3.
What is the Book Value of Deccan Cements Ltd?
The Book Value of Deccan Cements Ltd is 533.
What is the Dividend Yield of Deccan Cements Ltd?
The Dividend Yield of Deccan Cements Ltd is 0.08 %.
What is the ROCE of Deccan Cements Ltd?
The ROCE of Deccan Cements Ltd is 1.53 %.
What is the ROE of Deccan Cements Ltd?
The ROE of Deccan Cements Ltd is 0.75 %.
What is the Face Value of Deccan Cements Ltd?
The Face Value of Deccan Cements Ltd is 5.00.